{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T04:03:50Z","timestamp":1774929830463,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jocn-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.jocn.2016.03.042","type":"journal-article","created":{"date-parts":[[2016,7,22]],"date-time":"2016-07-22T05:51:58Z","timestamp":1469166718000},"page":"148-153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Quantitative analysis of brain edema in patients with malignant glioma treated with BCNU wafers"],"prefix":"10.1016","volume":"33","author":[{"given":"Satoshi","family":"Murai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomotsugu","family":"Ichikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"Kurozumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosuke","family":"Shimazu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuo","family":"Oka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Otani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiko","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isao","family":"Date","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2016.03.042_b0005","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocn.2016.03.042_b0010","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJMoa1308345","article-title":"Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma","volume":"370","author":"Chinot","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocn.2016.03.042_b0015","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/S1470-2045(14)70379-1","article-title":"Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071\u201322072 study): a multicentre, randomised, open-label, phase 3 trial","volume":"15","author":"Stupp","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jocn.2016.03.042_b0020","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s11060-011-0529-1","article-title":"A multicenter phase I trial of combination therapy with interferon-\u03b2 and temozolomide for high-grade gliomas (INTEGRA study): the final report","volume":"104","author":"Wakabayashi","year":"2011","journal-title":"J Neurooncol"},{"key":"10.1016\/j.jocn.2016.03.042_b0025","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3171\/jns.1991.74.3.0441","article-title":"Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas","volume":"74","author":"Brem","year":"1991","journal-title":"J Neurosurg"},{"key":"10.1016\/j.jocn.2016.03.042_b0030","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/00006123-199707000-00011","article-title":"Interstitial chemotherapy with carmustine-loaded polymers for high-grade gliomas: a randomized double-blind study","volume":"41","author":"Valtonen","year":"1997","journal-title":"Neurosurgery"},{"key":"10.1016\/j.jocn.2016.03.042_b0035","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/neuonc\/5.2.79","article-title":"A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma","volume":"5","author":"Westphal","year":"2003","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.jocn.2016.03.042_b0040","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3171\/2008.5.17557","article-title":"Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme","volume":"110","author":"McGirt","year":"2009","journal-title":"J Neurosurg"},{"key":"10.1016\/j.jocn.2016.03.042_b0045","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1185\/03007990802508180","article-title":"Safety profile of carmustine wafers in malignant glioma: a review of controlled trials and a decade of clinical experience","volume":"24","author":"Sabel","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jocn.2016.03.042_b0050","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1055\/s-0029-1242775","article-title":"Risk management in the treatment of malignant gliomas with BCNU wafer implants","volume":"71","author":"Giese","year":"2010","journal-title":"Cent Eur Neurosurg"},{"key":"10.1016\/j.jocn.2016.03.042_b0055","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s11060-013-1110-x","article-title":"The combination of carmustine wafers and temozolomide for the treatment of malignant gliomas. A comprehensive review of the rationale and clinical experience","volume":"113","author":"Gutenberg","year":"2013","journal-title":"J Neurooncol"},{"key":"10.1016\/j.jocn.2016.03.042_b0060","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s11060-011-0577-6","article-title":"Postoperative seizure in high grade glioma patients treated with BCNU wafers. A mono-institutional experience","volume":"105","author":"Della Puppa","year":"2011","journal-title":"J Neurooncol"},{"key":"10.1016\/j.jocn.2016.03.042_b0065","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00701-013-1931-6","article-title":"Evaluation of post-operative complications associated with repeat resection and BCNU wafer implantation in recurrent glioblastoma","volume":"156","author":"Samis Zella","year":"2014","journal-title":"Acta Neurochir (Wien)"},{"key":"10.1016\/j.jocn.2016.03.042_b0070","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s10143-010-0280-7","article-title":"First-line treatment of malignant glioma with carmustine implants followed by concomitant radiochemotherapy: a multicenter experience","volume":"33","author":"Bock","year":"2010","journal-title":"Neurosurg Rev"},{"key":"10.1016\/j.jocn.2016.03.042_b0075","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jocn.2016.03.042_b0080","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1245\/s10434-008-0048-2","article-title":"Use of Gliadel (BCNU) wafer in the surgical treatment of malignant glioma: a 10-year institutional experience","volume":"15","author":"Attenello","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jocn.2016.03.042_b0085","doi-asserted-by":"crossref","first-page":"290","DOI":"10.2176\/nmc.oa2013-0112","article-title":"A multicenter phase I\/II study of the BCNU implant (Gliadel(\u00ae) Wafer) for Japanese patients with malignant gliomas","volume":"54","author":"Aoki","year":"2014","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"10.1016\/j.jocn.2016.03.042_b0090","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1215\/S1152851704000614","article-title":"Cerebral edema associated with Gliadel wafers: two case studies","volume":"7","author":"Weber","year":"2005","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.jocn.2016.03.042_b0095","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1023\/A:1016083113123","article-title":"Chemotherapeutic drugs released from polymers: distribution of 1,3-bis(2-chloroethyl)-1-nitrosourea in the rat brain","volume":"13","author":"Fung","year":"1996","journal-title":"Pharm Res"},{"key":"10.1016\/j.jocn.2016.03.042_b0100","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2165\/00003088-200241060-00002","article-title":"Pharmacokinetics of the carmustine implant","volume":"41","author":"Fleming","year":"2002","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jocn.2016.03.042_b0105","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1200\/JCO.2003.09.041","article-title":"Dose escalation of carmustine in surgically implanted polymers in patients with recurrent malignant glioma: a New Approaches to Brain Tumor Therapy CNS Consortium trial","volume":"21","author":"Olivi","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jocn.2016.03.042_b0110","first-page":"375","article-title":"Number of wafers used in a cohort of 322 patients implanted with Gliadel wafer","volume":"6","author":"Golden","year":"2004","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.jocn.2016.03.042_b0115","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11060-006-9303-1","article-title":"Interstitial chemotherapy for malignant gliomas: the Johns Hopkins experience","volume":"83","author":"Lawson","year":"2007","journal-title":"J Neurooncol"},{"key":"10.1016\/j.jocn.2016.03.042_b0120","first-page":"708","article-title":"Current status of BCNU stent in the brain for treatment of glioma","volume":"40","author":"Aoki","year":"2013","journal-title":"Gan To Kagaku Ryoho"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586816303812?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586816303812?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T12:10:58Z","timestamp":1568203858000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586816303812"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":24,"alternative-id":["S0967586816303812"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2016.03.042","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantitative analysis of brain edema in patients with malignant glioma treated with BCNU wafers","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2016.03.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}